US International Trade Commission Plans To Review COVID-19 Patent Policy

The commission is reviewing a World Trade Organization proposal that would result in weaker patent protections for COVID-19 diagnostics and therapeutics. A public meeting will be held in March. 

Smartphone with logo of American International Trade Commission (USITC) on screen in front of website.
• Source: Shutterstock

The US International Trade Commission (ITC) has launched a review to determine how a proposed international policy that would grant fewer intellectual property protections to COVID-19 diagnostics and therapeutics might affect medical innovation.

The issue stems from the World Trade Organization’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), which was reached...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legal & IP

More from Policy & Regulation

FDA Commissioner’s Voucher Program Should Include Devices, Transplant Technology Firm Says

 
• By 

The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.

HealthAI: ‘Established Regulations Already Exist For Regulating AI In Healthcare Safely’

 

Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.

EUDAMED Notice Anticipated By September As Commission Optimizes Operations

 

The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.